What is the global market size of Neuroprosthetics Market?

Neuroprosthetics Market size was valued at USD 21.5 billion in 2021 and is poised to grow from USD 24.03 billion in 2022 to USD 54.17 billion by 2030, growing at a CAGR of 11.8% in the forecast period (2023-2030).

Who are the key vendors in the Global Neuroprosthetics Market?

Global neuroprosthetics market is moderately consolidated in nature with a few levels of players operating on global and regional basis such as Medtronic, Abbott, Cochlear Ltd., and Boston Scientific Corporation. Key players are implementing on several business strategies like strategic alliance, platform development, collaboration, and partnerships to expand their geographical presence and expanding their product portfolio. 'Abbott Laboratories', 'Boston Scientific Corporation', 'Cochlear Limited', 'Cyberonics, Inc. (LivaNova PLC)', 'Edwards Lifesciences Corporation', 'Envoy Medical Corporation', 'Medtronic plc', 'MicroPort Scientific Corporation', 'NDI Medical LLC', 'NeuroPace, Inc.', 'Nevro Corp.', 'Otto Bock HealthCare GmbH', 'Retina Implant AG', 'Second Sight Medical Products, Inc.', 'Sonova Holding AG', 'St. Jude Medical, Inc. (Abbott Laboratories)', 'Synapse Biomedical, Inc. (Zynex, Inc.)', 'Terumo Corporation', 'Thoratec Corporation (Abbott Laboratories)', 'Zimmer Biomet Holdings, Inc.'.

Neuroprosthetics Market Size, Share, Growth Analysis, By Type(Output Neural Prosthetics [Motor Prosthetics, Cognitive Prosthetics], Input Neural Prosthetics [Cochlear Implants, Bionic Eye/Retinal Implants]), By Technique(Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation), By Application(Motor Neuron Disorders (Parkinson’S Disease, Epilepsy), Physiological Disorders (Auditory Processing Disorders, Ophthalmic Disorders), By Region - Industry Forecast 2024-2031

Report ID: SQMIG35A2517 | Region: Global | Published Date: October, 2024
Pages: 157 | Tables: 90 | Figures: 76

Neuroprosthetics Market News

In April 2021, Houston Methodist and Rice University announced their launching of neuroprosthetics collaboration center for Translational Neural Prosthetics to focus on the restoring of a brain after any disease and injury. Houston Methodist and Rice University came into a strategic partnership to launch the center.
In July 2021, Researchers of US San Francisco has successfully developed a “speech neuroprosthesis” which enables a human with severe paralysis to communicate in sentences and help to translate signals from a human brain to vocal tract directly into words and that clearly appears on a screen as a text.

Neuroprosthetics Market Report Snapshots

License Type Top market research company in USA

File Type

$5,300

BUY NOW GET FREE SAMPLE

Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

Global Neuroprosthetics Market size was valued at USD 10.3 billion in 2022 and is poised to grow from USD 11.59 billion in 2023 to USD 29.73 billion by 2031, growing at a CAGR of 12.50% during the forecast period (2024-2031).

Global neuroprosthetics market is moderately consolidated in nature with a few levels of players operating on global and regional basis such as Medtronic, Abbott, Cochlear Ltd., and Boston Scientific Corporation. Key players are implementing on several business strategies like strategic alliance, platform development, collaboration, and partnerships to expand their geographical presence and expanding their product portfolio. 'Medtronic (US) ', 'Abbott (US) ', 'Cochlear (Australia) ', 'Boston Scientific (US) ', 'Livanova (UK) ', 'Med-El (Austria) ', 'Sonova (Switzerland) ', 'Neuropace (U S) ', 'NDI Medical (Canada) ', 'Nevro (US) ', 'SensArs Neuroprosthetics (Switzerland) ', 'NeuroPace, Inc. (US) ', 'Pixium Vision (France) ', 'NeuroSigma, Inc. (US) ', 'Axonics Modulation Technologies, Inc. (US) ', 'Nervo Corp (US) ', 'Soterix Medical, Inc. (US) ', 'Aleva Neurotherapeutics SA (Switzerland) ', 'Synapse Biomedical, Inc. (US) ', 'Cleveland FES Center (US)'

High prevalence of neurological disorders and injuries related to nerve is expected to be the key driving factors for the global neuroprosthetics market during the forecast period. For instance, neurological diseases accounted for more than 533,000 deaths, with number of males reported nearly 213,000 and number of females reported around 320,000. Neuroprosthetics devices can help in the treatment of these types of diseases owing to its several numbers of benefits. Moreover, patient with hearing problems can also get benefits from these devices such as cochlear and ABI. Hence, the global demand for neuroprosthetics for the diagnosis of several disorders are likely to fuel the growth of the market in the coming years.

The input neural prosthetics is getting more popularity owing to the growing burden of hearing loss and advancements in technology for the development of the various devices. Due to the features like providing sense of sound to a person who is proudly deaf and hard-of hearing, easy to use, and low implementation cost are creating lucrative growth opportunities for this prosthetics in the next coming years. According to our findings, cochlear implantation was found for not only the diagnosis of hearing loss but also suggested to use as a depression rehabilitation tool for tinnitus patients. Therefore, the neuroprosthetics market is expected to show an extensive growth in the next few years.

North America dominated the global neuroprosthetics market with a holding of significant market share in 2021 and is expected to maintain its dominance throughout the forecast period. Rising incidences of vision and hearing loss among people, advanced healthcare infrastructure, and presence of key market players are the major factors driving the growth of the market in the region. According to the Parkinson’s Foundation, around 1 million people are suffering with Parkinson’s diseases in the United States. Similarly, according to Centers for Disease Control and Prevention, nearly 3.4 million people in the United States have epilepsy disease including 3 million adults and 470,000 children, and the number of epilepsy among children is expected to reach a value of 1.2 million by 2030. As a result, the demand for neuroprosthetics is projected to rise during the forecast period.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Neuroprosthetics Market News

Neuroprosthetics Market Report Snapshots

Want to customize this report?

FAQs

What is the global market size of Neuroprosthetics Market?

Who are the key vendors in the Neuroprosthetics Market?

What is the key driver of Neuroprosthetics Market?

What is the key market trend for Neuroprosthetics Market?

Which region accounted for the largest share in Neuroprosthetics Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300